Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

Alkis, N.; Demirci, U.; Benekli, M.; Yilmaz, U.; Isikdogan, A.; Sevinc, A.; Ozdemir, N.; Koca, D.; Yetisyigit, T.; Kaplan, M.; Uncu, D.; ÜNEK, TARKAN; Gumus, M.

Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

Atıf İçin Kopyala

Alkis N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., ...Daha Fazla

JOURNAL OF BUON, cilt.16, sa.1, ss.80-83, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 1
Basım Tarihi: 2011
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.80-83
Anahtar Kelimeler: fluoropyrimidines, metastatic colorectal cancer, mitomycin-C, salvage therapy, 5-FLUOROURACIL, CHEMOTHERAPY, LEUCOVORIN, FLUOROURACIL, CARCINOMA, TRIAL
Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Purpose: To retrospectively evaluate the efficacy and tolerability of mitomycin-C (MMC) in combination with fluoropyrimidines as salvage 3rd -or 4th-line therapy in metastatic colorectal cancer (MCRC) patients.